Insights

Partnership Expansion Ablynx has recently partnered with Taisho Pharmaceutical Co., Ltd., indicating potential collaboration opportunities in pharmaceutical development and commercialization.

Technology Collaboration The collaboration with LabGenius on machine learning for protein engineering presents a chance for Ablynx to leverage advanced technologies and expand its product portfolio through innovative solutions.

Market Penetration With the acquisition of Corvidia and the development of an mRNA vaccine for Covid-19, Ablynx is strategically positioning itself in the competitive cardiovascular treatment and pandemic response markets, offering avenues for new product launches and market penetration.

Financial Potential Ablynx's revenue of $50M - $100M and funding of $230M demonstrate financial stability and the capacity for investment in new projects, representing potential sales opportunities for vendors and service providers within the biotechnology sector.

Innovation Focus As a pioneer in Nanobodies® development, Ablynx's focus on breakthrough innovation and commitment to addressing serious diseases hints at future collaborations and opportunities for partnerships in the biotechnology research space.

Ablynx Tech Stack

Ablynx uses 8 technology products and services including Docker, SAP, Eblox, and more. Explore Ablynx's tech stack below.

  • Docker
    Containerization
  • SAP
    Customer Relationship Management
  • Eblox
    E-commerce Platforms
  • jQuery
    Javascript Libraries
  • CTT
    Logistics
  • Python
    Programming Languages
  • IIS
    Web Servers
  • Twitter
    Widgets

Media & News

Ablynx's Email Address Formats

Ablynx uses at least 1 format(s):
Ablynx Email FormatsExamplePercentage
First.Last@ablynx.comJohn.Doe@ablynx.com
80%
FLast@ablynx.comJDoe@ablynx.com
13%
FMiddleLast@ablynx.comJMichaelDoe@ablynx.com
5%
First.Middle.Last@ablynx.comJohn.Michael.Doe@ablynx.com
2%

Frequently Asked Questions

Where is Ablynx's headquarters located?

Minus sign iconPlus sign icon
Ablynx's main headquarters is located at Technologiepark 21 Zwijnaarde (Ghent), 9052 BE. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Ablynx's phone number?

Minus sign iconPlus sign icon
You can contact Ablynx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ablynx's stock symbol?

Minus sign iconPlus sign icon
Ablynx is a publicly traded company; the company's stock symbol is ABLX.

What is Ablynx's official website and social media links?

Minus sign iconPlus sign icon
Ablynx's official website is ablynx.com and has social profiles on LinkedIn.

How much revenue does Ablynx generate?

Minus sign iconPlus sign icon
As of June 2024, Ablynx's annual revenue reached $75M.

What is Ablynx's SIC code NAICS code?

Minus sign iconPlus sign icon
Ablynx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ablynx have currently?

Minus sign iconPlus sign icon
As of June 2024, Ablynx has approximately 201 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Head Glp Qa: C. D.Executive Assistant To Chief Medical Officer: R. V. R.Cfo: W. O.. Explore Ablynx's employee directory with LeadIQ.

What industry does Ablynx belong to?

Minus sign iconPlus sign icon
Ablynx operates in the Biotechnology Research industry.

What technology does Ablynx use?

Minus sign iconPlus sign icon
Ablynx's tech stack includes DockerSAPEbloxjQueryCTTPythonIISTwitter.

What is Ablynx's email format?

Minus sign iconPlus sign icon
Ablynx's email format typically follows the pattern of . Find more Ablynx email formats with LeadIQ.

How much funding has Ablynx raised to date?

Minus sign iconPlus sign icon
As of June 2024, Ablynx has raised $230M in funding. The last funding round occurred on Oct 30, 2017 for $230M.
Ablynx

Ablynx

Biotechnology ResearchZwijnaarde (Ghent), Belgium201-500 Employees

Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Nanobodies have potential uses in the treatment of a range of serious and life-threatening human diseases. Ablynx advances a portfolio of Nanobody-based therapeutic programs in several major disease areas, including inflammation, haematology, immuno-oncology and oncology.

The acquisition of Ablynx (June 2018) continues Sanofi’s commitment to breakthrough innovation, focused on technologies addressing multiple disease targets with single multi-specific molecules. Sanofi is committed to accelerating Ablynx’s Nanobody development programmes.

Section iconCompany Overview

Headquarters
Technologiepark 21 Zwijnaarde (Ghent), 9052 BE
Phone number
Website
ablynx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ABLX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $230M

    Ablynx has raised a total of $230M of funding over 8 rounds. Their latest funding round was raised on Oct 30, 2017 in the amount of $230M.

  • $50M$100M

    Ablynx's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $230M

    Ablynx has raised a total of $230M of funding over 8 rounds. Their latest funding round was raised on Oct 30, 2017 in the amount of $230M.

  • $50M$100M

    Ablynx's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.